Tore Haslemo
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
- Pharmacology 19
- Pharmacogenetics and Drug Metabolism 19
- Treatment of Major Depression 3
-
- Schizophrenia research and treatment 9
- Epilepsy research and treatment 1
- Co-authors
- Espen Molden (34 shared papers)Magnus Ingelman‐Sundberg (7 shared papers)Marin M. Jukić (6 shared papers)Robert L. Smith (8 shared papers)Helge Refsum (5 shared papers)Lars Tanum (1 shared paper)Erik Eliasson (4 shared papers)H. Refsum (2 shared papers)
In The Last Decade
Tore Haslemo
35 papers receiving 912 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 395
- Psychiatry and Mental health 332
- Biological Psychiatry 53
- Pediatrics, Perinatology and Child Health 143
- Pharmacology 125
Countries citing papers authored by Tore Haslemo
This map shows the geographic impact of Tore Haslemo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tore Haslemo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tore Haslemo more than expected).
Fields of papers citing papers by Tore Haslemo
This network shows the impact of papers produced by Tore Haslemo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tore Haslemo. The network helps show where Tore Haslemo may publish in the future.
Co-authors
The 25 scholars most cited alongside Tore Haslemo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 129 | |
| 2 | 2006 | 126 | |
| 3 | 2019 | 114 | |
| 4 | 2006 | 45 | |
| 5 | 2021 | 31 | |
| 6 | 2018 | 31 | |
| 7 | 2015 | 31 | |
| 8 | 2016 | 31 | |
| 9 | 2012 | 29 | |
| 10 | 2012 | 28 | |
| 11 | 2015 | 28 | |
| 12 | 2019 | 28 | |
| 13 | 2018 | 27 | |
| 14 | 2012 | 25 | |
| 15 | 2020 | 23 | |
| 16 | 2019 | 21 | |
| 17 | 2016 | 21 | |
| 18 | 2013 | 21 | |
| 19 | 2017 | 20 | |
| 20 | 2018 | 17 |
About Tore Haslemo
Tore Haslemo is a scholar working on Pharmacology, Psychiatry and Mental health, Pharmacology, Surgery and Pediatrics, Perinatology and Child Health, having authored 37 papers that have together received 940 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Schizophrenia research and treatment (9 papers), Treatment of Major Depression (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Cholesterol and Lipid Metabolism (2 papers), Mental Health and Psychiatry (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Pharmacology (395 citations), Psychiatry and Mental health (332 citations), Biological Psychiatry (53 citations), Pediatrics, Perinatology and Child Health (143 citations) and Pharmacology (125 citations). Tore Haslemo has collaborated with scholars based in Norway, Sweden and Serbia. Frequent co-authors include Espen Molden, Magnus Ingelman‐Sundberg, Marin M. Jukić, Robert L. Smith, Helge Refsum, Lars Tanum, Erik Eliasson, H. Refsum, Kristine Hole and Marianne Kristiansen Kringen. Their work appears in journals such as Therapeutic Drug Monitoring, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Journal of Clinical Psychopharmacology and Basic & Clinical Pharmacology & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.